|
Variable
|
LVNC (N = 28)
|
Hypertrabeculation (N = 28)
|
Normal (N = 28)
|
|---|
|
Age (years)
|
14(4)
|
12(3) p = 0.098*
|
13(3) p = 0.512**
|
|
Male/Female
|
16/12
|
18/10 p = 0.594*
|
18/10 p = 1.000**
|
|
Weight (kg)
|
51(18)
|
47(16) p = 0.238*
|
49(17) p = 0.422**
|
|
Height (cm)
|
156 (22)
|
154(16) p = 0.550*
|
156(19) p = 0.617**
|
|
BSA (m2)
|
1.48 (0.35)
|
1.41(0.31) p = 0.321*
|
1.45(0.35). p = 0.461**
|
|
Fractal global
|
1.345(0.053)
|
1.252(0.034) p < 0.001*
|
1.158(0.038) p < 0.001**
|
|
Fractal max
|
1.475(0.041)
|
1.346(0.027) p < 0.001*
|
1.259(0.043) p < 0.001**
|
|
Petersen
|
2.8(0.4)
|
1.8(0.2) p < 0.001*
|
1.1(0.1) p < 0.001**
|
|
Jacquier
|
0.35(0.10)
|
0.19(0.07) p < 0.001*
|
0.14(0.08). p = 0.012**
|
|
LVEDVI (ml/m2)
|
67(15)
|
67(11) p = 0.658*
|
65(11) p = 0.870**
|
|
LVESVI (ml/m2)
|
27(11)
|
24(7) p = 0.566*
|
22(5) p = 0.522**
|
|
LVSVI (ml/m2)
|
40(9)
|
43(8) p = 0.209*
|
43(8) p = 0.837**
|
|
LVEF (%)
|
61(11)
|
65(7) p = 0.189*
|
66(5) p = 0.594**
|
|
LV mass (g/m2)a
|
96(18)
|
82(15) p = 0.002*
|
69(10) p < 0.001**
|
- Mean (SEM)
- *Wilcoxon test comparing LVNC and hypertrabeculation groups
- **Wilcoxon test comparing hypertrabeculation group and normal controls
- aTrabeculations were included in the global LV mass for our volumetric analysis, therefore the difference in LV mass index between groups is significant
- BSA body surface area, LV left ventricular, LVEDVI left ventricular end-diastolic volume index, LVEF left ventricular ejection fraction, LVESVI left ventricular end-systolic volume index, LVNC left ventricular non-compaction, LVSVI left ventricular stroke volume index
